The pleiotropic effects of Kaposi's sarcoma herpesvirus

被引:128
作者
Schulz, TF [1 ]
机构
[1] Hannover Med Sch, Dept Virol, D-30625 Hannover, Germany
关键词
Kaposi's sarcoma herpesvirus; Kaposi's sarcoma; multicentric Castleman's disease; primary effusion lymphoma; immunosuppression;
D O I
10.1002/path.1904
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kaposi's sarcoma herpesvirus (KSHV), or human herpesvirus 8 (HHV8), is an essential factor in the pathogenesis of Kaposi's sarcoma (KS), multicentric Castleman's disease (MCD), and primary effusion lymphoma (PEL). Case reports suggest an occasional involvement in bone marrow hypoplasia and haemophagocytic syndrome, but other disease associations are unconfirmed or controversial. KSHV-associated disease is of particular importance in immunosuppressed individuals, in particular in patients with HIV infection and transplant recipients. KSHV establishes a latent infection in the majority of infected cells in KS, MCD, and PEL, but lytic replication occurs in a small fraction of infected cells. Viral proteins expressed during both the latent and the lytic phase of the viral life cycle contribute to the pathogenesis of KSHV-associated diseases. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 164 条
[1]   Dissolution of the lymphoid follicle is a feature of the HHV8+variant of plasma cell Castleman's disease [J].
Amin, HM ;
Medeiros, LJ ;
Manning, JT ;
Jones, D .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (01) :91-100
[2]   The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest [J].
An, FQ ;
Compitello, N ;
Horwitz, E ;
Sramkoski, M ;
Knudsen, ES ;
Renne, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3862-3874
[3]   High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission [J].
Andreoni, M ;
El-Sawaf, G ;
Rezza, G ;
Ensoli, B ;
Nicastri, E ;
Ventura, L ;
Ercoli, L ;
Sarmati, L ;
Rocchi, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) :465-469
[4]  
[Anonymous], 1997, IARC MONOGRAPHS EVAL
[5]   Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas [J].
Aoki, Y ;
Tosato, G .
BLOOD, 1999, 94 (12) :4247-4254
[6]   Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions [J].
Aoki, Y ;
Yarchoan, R ;
Braun, J ;
Iwamoto, A ;
Tosato, G .
BLOOD, 2000, 96 (04) :1599-1601
[7]  
Aoki Yoshiyasu, 1999, Blood, V93, P4034
[8]   Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [J].
Arvanitakis, L ;
GerasRaaka, E ;
Varma, A ;
Gershengorn, MC ;
Cesarman, E .
NATURE, 1997, 385 (6614) :347-350
[9]   Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells [J].
Asou, H ;
Said, JW ;
Yang, R ;
Munker, R ;
Park, DJ ;
Kamada, N ;
Koeffler, HP .
BLOOD, 1998, 91 (07) :2475-2481
[10]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644